Tramadol Hydrochloride
Product Images NDC 50436-0698

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 50436-0698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of Tramadol Hydrochloride showing its molecular arrangement including rings, hydroxyl, methyl, and amine groups linked to a cyclohexane ring and a methyl phenyl ether fragment.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph comparing Tramadol concentration (ng/mL) over 24 hours for two formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (solid circles) and Tramadol Hydrochloride Tablets 50 mg every 6 hours (open circles). The y-axis shows Tramadol concentration from 0 to 350 ng/mL, and the x-axis represents time in hours from 0 to 24.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

Line graph comparing plasma concentration over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The y-axis represents M1 metabolite concentration in ng/mL, and the x-axis shows time in hours.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Line chart showing the percentage of patients achieving response at varying response thresholds in a study of Tramadol Hydrochloride Extended-Release Tablets. The graph compares four dosages (100 mg, 200 mg, 300 mg, 400 mg) and placebo, depicting percent patients achieving response on the Y-axis against response threshold (percent improvement from baseline) on the X-axis.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis Patients Achieving Various Levels of Response Threshold.' The x-axis shows Response Threshold as Percent Improvement from Baseline (0 to 100%), and the y-axis shows Percent of Patients Achieving Response (0 to 60%). Two lines compare Tramadol Hydrochloride Extended-Release Tablets and Placebo, illustrating patient response rates decreasing with higher response thresholds.*

FDA Label Image

Label Image (Lbl504360698)

TRAMADOL HYDROCHLORIDE Extended-Release 200 mg tablet blister pack containing 30 tablets. Label shows Unit Dose Services as the labeler and Lupin Pharm, Inc., Baltimore, Maryland as the manufacturer. Includes storage instructions to keep at 25 °C and out of reach of children. The label indicates the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.